<DOC>
	<DOC>NCT01470612</DOC>
	<brief_summary>This study is an open label, long-term extension study for subjects with moderate to severe ulcerative colitis designed to evaluate long term therapy of CP-690,550.</brief_summary>
	<brief_title>Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis, Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Tofacitinib</mesh_term>
	<criteria>Subjects who completed induction studies A3921094 or A3921095 and were classified as not meeting clinical response criteria; OR Subjects who completed maintenance study A3921096 or who discontinued treatment early in Study A3921096 due to treatment failure. Subjects who had a major protocol violation in Study A3921094, A3921095 or A3921096. Presence of indeterminate colitis, microscopic colitis, ischemic colitis, infectious colitis, or clinical findings suggestive of Crohn's disease. Subjects who have had surgery for ulcerative colitis or in the opinion of the investigator, are likely to require surgery for ulcerative colitis during the study period.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Ulcerative colitis</keyword>
	<keyword>open-label</keyword>
	<keyword>long term treatment</keyword>
</DOC>